Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study

by Haissam Haddad, MD, FRCPC, Sebastien Bergeron, MD, FRCPC, Andrew Ignaszewski, MD, FRCPC, Gregory Searles, MD, FRCPC, Driss Rochdi, PhD, Priyanka Dhage, MStat, Natacha Bastien, PhD
Published 2020-09-01